Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US

Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum

South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...

President Lee meets Hyundai, LG chiefs, promotes ‘one team’ approach Hanwan Ocean wins $1.4 bn order to build 7 LNG dual-fuel ships K-content reign continues as Squid Game returns in force South Korea’s EV exports rebound in June after 16-month decline Yes, it’s K-beauty: Strong buying appetite for makeup brands even before they're up for sale
banner